BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16247976)

  • 21. [Phosphoramidate derivatives of acyclovir--herpes virus replication inhibitors].
    Zakirova NF; Shipitsyn AV; Ias'ko MV; Kochetkov SN
    Bioorg Khim; 2011; 37(5):645-53. PubMed ID: 22332360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleoside transport inhibitors, dipyridamole and p-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011.
    Boyer CR; Karjian PL; Wahl GM; Pegram M; Neuteboom ST
    Anticancer Drugs; 2002 Jan; 13(1):29-36. PubMed ID: 11914638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designing a pronucleotide stratagem: lessons from amino acid phosphoramidates of anticancer and antiviral pyrimidines.
    Drontle DP; Wagner CR
    Mini Rev Med Chem; 2004 May; 4(4):409-19. PubMed ID: 15134543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
    Wu W; Borch RF
    Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and anticancer activity of some 5-fluoro-2'-deoxyuridine phosphoramidates.
    Lewandowska M; Ruszkowski P; Chojnacka K; Kleczewska N; Hoffmann M; Kacprzak K; Celewicz L
    Bioorg Med Chem; 2016 May; 24(10):2330-41. PubMed ID: 27073055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antiviral activity of aryl phosphoramidate derivatives of beta-D- and beta-L-C-5-substituted 2',3'-didehydro-2',3'-dideoxy-uridine bearing linker arms.
    Ladurée D; Fossey C; Delbederi Z; Sugeac E; Schmidt S; Laumond G; Aubertin AM
    J Enzyme Inhib Med Chem; 2005 Dec; 20(6):533-49. PubMed ID: 16408789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model synthesis of nucleoside boranophosphoramidate with amino acid for prodrug purpose.
    Li P; Shaw BR
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):675-8. PubMed ID: 16248012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and metabolism of naphthyl substituted phosphoramidate derivatives of stavudine.
    Venkatachalam TK; Qazi S; Uckun FM
    Bioorg Med Chem; 2006 Aug; 14(15):5161-77. PubMed ID: 16697204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives.
    Mehellou Y; McGuigan C; Brancale A; Balzarini J
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3666-9. PubMed ID: 17485204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of the hydrolysis pathways of substituted aryl phosphoramidate versus aryl thiophosphoramidate derivatives of stavudine.
    Venkatachalam TK; Yu G; Samuel P; Qazi S; Pendergrass S; Uckun FM
    Eur J Med Chem; 2004 Aug; 39(8):665-83. PubMed ID: 15276300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parallel solid-phase synthesis of nucleoside phosphoramidate libraries.
    Jin Y; Chen X; Côté M; Roland A; Korba B; Mounir S; Iyer RP
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2057-60. PubMed ID: 11514138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CycloSal-BVDUMP pronucleotides: how to convert an antiviral-inactive nucleoside analogue into a bioactive compound against EBV.
    Meier C; Lomp A; Meerbach A; Wutzler P
    J Med Chem; 2002 Nov; 45(23):5157-72. PubMed ID: 12408726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aryloxy phosphoramidate triesters as pro-tides.
    Cahard D; McGuigan C; Balzarini J
    Mini Rev Med Chem; 2004 May; 4(4):371-81. PubMed ID: 15134540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphoramidate derivatives of 2',5'-dideoxyadenosine as potential inhibitors of the EDHF phenomenon.
    Gavazza F; Daverio F; Chaytor AT; Griffith TM; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):553-5. PubMed ID: 16247988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential of bromovinyldeoxyuridine in anticancer chemotherapy.
    De Clercq E
    Anticancer Res; 1986; 6(4):549-56. PubMed ID: 3752935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphoramidate protides of five flavones and their antiproliferative activity against HepG2 and L-O2 cell lines.
    Li YQ; Yang F; Wang L; Cao Z; Han TJ; Duan ZA; Li Z; Zhao WJ
    Eur J Med Chem; 2016 Apr; 112():196-208. PubMed ID: 26896708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modelling studies on the binding of some protides to the putative human phosphoramidase Hint1.
    Congiatu C; Brancale A; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1121-4. PubMed ID: 18058549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-beta-D-(arabinofuranosyl)uracil phosphoramidate ProTides.
    Mehellou Y; Balzarini J; McGuigan C
    Antivir Chem Chemother; 2010 Mar; 20(4):153-60. PubMed ID: 20231780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel approach to thymidylate synthase as a target for cancer chemotherapy.
    Li Q; Boyer C; Lee JY; Shepard HM
    Mol Pharmacol; 2001 Mar; 59(3):446-52. PubMed ID: 11179438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antiviral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Balzarini J; Baumgartner H; Bodenteich M; De Clercq E; Griengl H
    J Med Chem; 1989 Aug; 32(8):1861-5. PubMed ID: 2547072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.